Population pharmacokinetics of tenofovir and tenofovir-diphosphate in healthy women. - Wikidata - wikimedia - TriplyDB

Population pharmacokinetics of tenofovir and tenofovir-diphosphate in healthy women.

Population pharmacokinetics of tenofovir and tenofovir-diphosphate in healthy women.

http://www.wikidata.org/entity/Q37224902

about

Historical development of vaginal microbicides to prevent sexual transmission of HIV in women: from past failures to future hopes.Plasma Tenofovir, Emtricitabine, and Rilpivirine and Intracellular Tenofovir Diphosphate and Emtricitabine Triphosphate Pharmacokinetics following Drug Intake Cessation.Model Linking Plasma and Intracellular Tenofovir/Emtricitabine with Deoxynucleoside Triphosphates.Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine After Directly Observed Dosing in Healthy Volunteers to Establish Adherence Benchmarks (HPTN 066)Pharmacologic Considerations for Preexposure Prophylaxis in Transgender Women.Population Pharmacokinetics of Tenofovir in HIV-1-Uninfected Members of Serodiscordant Couples and Effect of Dose Reporting Methods.Liquid chromatography-mass spectrometry methods for the intracellular determination of drugs and their metabolites: a focus on antiviral drugs.

P2860

Q33821090-693C6401-B1DE-40F6-95C7-00E72ADBE0FA Q36075954-5F571F59-E393-4612-B2FE-F5B6FBA55CCB Q36188725-C925A804-AFAC-4262-B137-F8194387D56D Q36406923-A87F43BA-2632-453E-812D-F5DAE98E9BCB Q37114554-3FEA6EC2-5D57-4B73-9A8F-040B4541BAAC Q37203867-231EBC8A-03D7-47DA-BD92-DDD5B1BB8F19 Q39434360-A0C49C36-C63E-4FDE-A175-362A55B77059

P2860

Population pharmacokinetics of tenofovir and tenofovir-diphosphate in healthy women.

http://www.wikidata.org/entity/Q37224902

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 February 2015

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Population pharmacokinetics of tenofovir and tenofovir-diphosphate in healthy women.

@en

Population pharmacokinetics of tenofovir and tenofovir-diphosphate in healthy women.

@nl

type

label

Population pharmacokinetics of tenofovir and tenofovir-diphosphate in healthy women.

@en

Population pharmacokinetics of tenofovir and tenofovir-diphosphate in healthy women.

@nl

prefLabel

Population pharmacokinetics of tenofovir and tenofovir-diphosphate in healthy women.

@en

Population pharmacokinetics of tenofovir and tenofovir-diphosphate in healthy women.

@nl

P1433

Q37224902-2A86E3EE-80F6-459B-8C4E-C06058C1F8CF

P1476

Q37224902-DC4E9CE7-58B0-4644-A782-C64249A68281

P2093

Q37224902-8C8539E0-4D11-4C66-A054-2F75C742184F

Q37224902-AA5C7534-F1D7-43ED-983E-E1CF401CE97F

Q37224902-F7976C0C-48FB-4337-B53A-0FA511F49341

P2860

Q37224902-140C0EE4-C68B-4008-B1AD-56FDEE98E8E8

Q37224902-17AAD6FD-AFAF-4CDE-B639-8A5C05E49AA3

Q37224902-1CDA765F-47C7-423E-ADEE-8C8B2458ED06

Q37224902-2882DA56-EFA7-4BDE-95FC-DBF0918A40AE

Q37224902-2B1063F1-1A40-48A4-9459-E26A47F7AA05

Q37224902-2B98B81C-B3EF-41B9-A512-6DF3A13AD445

Q37224902-39F4DE57-9BA4-42C0-AA30-E09FD6B0A902

Q37224902-42F841EA-923F-4E29-BB3F-88A78A3DF5F1

Q37224902-503B5D44-A2A8-4F12-BE4D-123BF3224CFF

Q37224902-5F297925-41AA-44F7-A6DB-3EC3AC06A5EF

P304

Q37224902-B80B8B89-AA16-4DF6-A8A5-0D8BF508CECF

P31

Q37224902-CCF1B15C-3B3B-41B7-A3C8-F68650DE0634

P356

Q37224902-3914BD39-4E6A-41D0-AD2F-EFF593C3E6DA

P433

Q37224902-84093479-EF68-4A92-B9E4-4A48C318ECFD

P478

Q37224902-5AAAFD23-BB96-4BE5-B9B9-A86C4B6524EC

P577

Q37224902-2177E0A3-D840-4ACC-8863-37422472BACE

P698

Q37224902-EF628596-4DE6-4CA5-BACD-40249F1FD82F

P932

Q37224902-50EFA4AB-ED3A-4BBA-9815-8CBA403A04B8

P356

P1433

The Journal of Clinical Pharmacology

P1476

Population pharmacokinetics of tenofovir and tenofovir-diphosphate in healthy women.

@en

P2093

Ayyappa Chaturvedula

http://www.w3.org/2001/XMLSchema#string

Craig W Hendrix

http://www.w3.org/2001/XMLSchema#string

Rebecca N Burns

http://www.w3.org/2001/XMLSchema#string

P2860

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

Estimation of population characteristics of pharmacokinetic parameters from routine clinical data

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial

Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA

Pharmacokinetics and pharmacodynamics of the reverse transcriptase inhibitor tenofovir and prophylactic efficacy against HIV-1 infection

MTN-001: randomized pharmacokinetic cross-over study comparing tenofovir vaginal gel and oral tablets in vaginal tissue and other compartments

Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana

Selecting reliable pharmacokinetic data for explanatory analyses of clinical trials in the presence of possible noncompliance.

Population one-compartment pharmacokinetic analysis with missing dosage data.

P304

629-638

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCPH.461

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25581815

http://www.w3.org/2001/XMLSchema#string

P932

5008110

http://www.w3.org/2001/XMLSchema#string